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Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA3) is a neurodegenerative disease 
with an autosomal dominant inheritance pattern. Nowadays, it is the most common form of spinocerebellar 
ataxia and an incurable disorder, which leads to death1.  
 
MJD is caused by the expansion of CAG trinucleotide repeat in the coding region of the gene ATXN3 and 
the aggregation of the resulting product. This polyQ expansion is thought to be the key of the disease, in 
which the length of this polyQ extension is linked to earlier and more severe symptons2. This mutant 
protein disturbs the normal neuronal function and leads to its degeneration, with subsequent formation of 
neuronal intranuclear inclusions. Although there is no treatment available, a more accurate diagnosis of 
MJD may lead to relieved symptoms2. Research activities targeting such possibility include the 
identification of biomarkers in several biological fluids that may turn out an important means to early 
diagnosis or even potential therapy biomarkers within future3,4. 
 
Thus, this work develops novel and low cost electrochemical (bio)sensing devices to detect ataxin 3 
protein (atx3), comprising a molecularly-imprinted polymer as biorecognition element. This element was 
obtained as an electrochemically synthesised molecularly-imprinted polymer (MIP) that was tyramine-
based. The tyramine monomer was mixed with atx3, on a carbon screen-printed electrode (SPE), and 
assembled as shown in scheme 1. The surface modification and the ability of the material to rebind the atx 
3 oligomers was measured by electrochemical techniques, namely electrochemical impedance 
spectroscopy, square wave voltammetry and cyclic voltammetry. 
 
The biorecognition element was successful constructed on the SPE. The control of the surface 
modification was evaluated electrochemically. Further tests are progressing to obtain a specific and 
sensitive biosensor for the detection of the target biomolecule. 
 
 
 
Scheme 2: Schematic representation of the construction steps of the biosensor, from electropolymerization with 
tyramine in conjunction with the biomarker (atx3 oligomers), to rebinding of atx3 that leads to the calibration, made with 
increasing concentrations atx3. 
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